Work

Exposure-Response Analyses Supporting Optimal Epcoritamab Full Dose and Dosing Schedule in Relapsed or Refractory Follicular Lymphoma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-197962

Authors: Mahipal Gurram Sinnollareddy, Leonid Gibiansky, Kinjal Sanghavi, Steven Xu, Mohamed-Eslam F Mohamed, Poliana P. Patah, Elena Favaro, Manish Gupta, Apurvasena Parikh, Tommy Li

Institutions: AbbVie (United States), Genmab (United States), Genmab (Denmark)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405041774

Cites:

Cited by:

Related to: 10